Chargement en cours...

培美曲塞单药或联合铂类三线及以上治疗晚期非鳞型非小细胞肺癌的临床观察

BACKGROUND AND OBJECTIVE: Pemetrexed in combination with platinum or a single-agent has been approved for the first- and second-line treatment of non-small cell lung cancer (NSCLC). However, the role of pemetrexed therapy in the third-line and beyond treatment of NSCLC has yet to be generally accept...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Zhongguo Fei Ai Za Zhi
Format: Artigo
Langue:Inglês
Publié: 中国肺癌杂志编辑部 2012
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6000264/
https://ncbi.nlm.nih.gov/pubmed/22336241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2012.02.10
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!